acetylcysteine has been researched along with Infections, Helicobacter in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 5 (29.41) | 29.6817 |
| 2010's | 10 (58.82) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, SY; Cui, Y; Hao, H; Hill, MA; Li, DP; Liu, X; Liu, Z; Martinez-Lemus, LA; Wang, M; Wu, H; Xia, X; Xu, C; Zhang, L; Zhu, Q | 1 |
| Bak, EJ; Cha, JH; Jang, S | 1 |
| Almarza, O; Álvarez, A; Antonelli, M; Canales, J; Cerda, O; Peña, MA; Romero, C; Soza, A; Toledo, H; Uribe, F | 1 |
| Chu, CH; Liao, PH; Lin, YC; Liou, TC; Shih, SC | 1 |
| Fontes, LES; Martimbianco, ALC; Riera, R; Zanin, C | 1 |
| Amini, M; Hossein Hosseini, S; Karbasi, A; Najafian, B; Shohrati, M | 1 |
| Cammarota, G; Gasbarrini, A; Gasbarrini, G; Ianiro, G | 1 |
| García, A; González, C; Herrera, C; Salas-Jara, MJ | 1 |
| Hwang, JH; Jang, ES; Jeong, SH; Kim, J; Kim, JW; Kim, N; Lee, DH; Park, YS; Shin, CM; Yoon, H | 1 |
| Ardito, F; Branca, G; Cammarota, G; Cianci, R; Fadda, G; Gasbarrini, A; Gasbarrini, G; Ianiro, G; Landolfi, R; Masala, G; Sanguinetti, M; Torelli, R | 1 |
| Butler, RN; Campbell, MA; Huynh, HQ; Kritas, S; Lee, SS; Tran, CD | 1 |
| Demirtürk, L; Diler, M; Oncül, O; Ozel, M; Tarçin, O; Yazgan, Y; Yildirim, S | 1 |
| Krishna, M; Lalmuanpuii, J | 1 |
| Demirturk, L; Gurbuz, AK; Ozel, AM; Ozturk, R; Yazgan, Y; Yildirim, S | 1 |
| Chang, CC; Chen, JN; Chen, SH; Chen, YF; Hsieh, CR; Lin, CP; Lou, HY; Pan, S; Suk, FM; Wu, MS | 1 |
| Cavallaro, LG; Cavestro, GM; Comparato, G; Di Mario, F; Fanigliulo, L; Franzè, A; Iori, V; Leandro, G; Maino, M; Martelli, L; Martelli, M; Morana, E; Nouvenne, A; Pilotto, A; Stefani, N | 1 |
| Ammann, R; Flury, R; Meyenberger, C; Wirth, HP; Wüst, J; Zala, G | 1 |
2 review(s) available for acetylcysteine and Infections, Helicobacter
| Article | Year |
|---|---|
N-acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication.
Topics: Acetylcysteine; Adolescent; Adult; Aged; Anti-Bacterial Agents; Chemotherapy, Adjuvant; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged; Randomized Controlled Trials as Topic; Young Adult | 2019 |
Biofilm and Helicobacter pylori: from environment to human host.
Topics: Acetylcysteine; Anti-Bacterial Agents; Biofilms; Curcumin; Environment; Environmental Microbiology; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Water Microbiology | 2014 |
9 trial(s) available for acetylcysteine and Infections, Helicobacter
| Article | Year |
|---|---|
Intraluminal therapy for Helicobacter pylori infection.
Topics: Acetylcysteine; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Expectorants; Female; Gastric Acid; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Metronidazole; Middle Aged; Powders; Prospective Studies; Proton Pump Inhibitors; Remission Induction; Therapeutic Irrigation; Time Factors; Treatment Outcome; Young Adult | 2019 |
Effect of oral N-acetyl cysteine on eradication of Helicobacter pylori in patients with dyspepsia.
Topics: Acetylcysteine; Administration, Oral; Adolescent; Adult; Aged; Double-Blind Method; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Remission Induction; Young Adult | 2013 |
Effects of N-acetylcysteine on First-Line Sequential Therapy for Helicobacter pylori Infection: A Randomized Controlled Pilot Trial.
Topics: Acetylcysteine; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Metronidazole; Middle Aged; Pilot Projects; Rabeprazole; Treatment Outcome | 2016 |
Biofilm demolition and antibiotic treatment to eradicate resistant Helicobacter pylori: a clinical trial.
Topics: Acetylcysteine; Anti-Bacterial Agents; Biofilms; Breath Tests; Drug Therapy, Combination; Expectorants; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Treatment Outcome; Urea | 2010 |
Does N-acetyl cystein affect the sensitivity and specificity of Helicobacter pylori stool antigen test?
Topics: Acetylcysteine; Administration, Oral; Adult; Antigens, Bacterial; Expectorants; Feces; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Predictive Value of Tests; Sensitivity and Specificity | 2003 |
Effect of N-acetyl cysteine on Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetylcysteine; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Expectorants; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Stomach Diseases | 2005 |
Premedication with pronase or N-acetylcysteine improves visibility during gastroendoscopy: an endoscopist-blinded, prospective, randomized study.
Topics: Acetylcysteine; Adult; Aged; Dimethylpolysiloxanes; Expectorants; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Premedication; Pronase; Prospective Studies; Single-Blind Method; Urease | 2007 |
A curcumin-based 1-week triple therapy for eradication of Helicobacter pylori infection: something to learn from failure?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetylcysteine; Adult; Aged; Curcumin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lactoferrin; Male; Middle Aged; Pantoprazole; Treatment Failure | 2007 |
[Omeprazole/amoxicillin: improved eradication of Helicobacter pylori in smokers because of N-acetylcysteine].
Topics: Acetylcysteine; Adult; Aged; Amoxicillin; Drug Therapy, Combination; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies | 1994 |
6 other study(ies) available for acetylcysteine and Infections, Helicobacter
| Article | Year |
|---|---|
Helicobacter pylori infection selectively attenuates endothelial function in male mice
Topics: Acetylcysteine; Animals; Atherosclerosis; Endothelial Cells; Endothelium; Exosomes; Female; Helicobacter Infections; Helicobacter pylori; Male; Mice; Mice, Inbred C57BL; Reactive Oxygen Species | 2023 |
N-acetylcysteine prevents the development of gastritis induced by Helicobacter pylori infection.
Topics: Acetylcysteine; Animals; Asymptomatic Infections; Bacterial Load; Culture Media; Diet; Disease Models, Animal; Gastritis; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Humans; Stomach | 2017 |
KCTD5 and Ubiquitin Proteasome Signaling Are Required for
Topics: Acetylcysteine; Adhesins, Bacterial; Antigens, Bacterial; Bacterial Proteins; Cell Line; Coculture Techniques; Cullin Proteins; Epithelial Cells; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Host-Pathogen Interactions; Humans; Lysosomes; Potassium Channels; Proteasome Endopeptidase Complex; Signal Transduction; Ubiquitin; Virulence Factors | 2017 |
Role of N-acetyl-cisteine in the treatment of H. pylori.
Topics: Acetylcysteine; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male | 2014 |
Novel combination therapy for the eradication of Helicobacter pylori infection in a mouse model.
Topics: Acetylcysteine; Amoxicillin; Animals; Anti-Bacterial Agents; Cattle; Colostrum; Disease Models, Animal; Drug Therapy, Combination; Female; Helicobacter Infections; Mice; Mice, Inbred C57BL; Treatment Outcome; Zinc | 2010 |
Helicobacter pylori treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetylcysteine; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Expectorants; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole | 2005 |